Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7.

Ning S, Pagano JS.

J Virol. 2010 Jun;84(12):6130-8. doi: 10.1128/JVI.00364-10. Epub 2010 Apr 14.

2.

IRF7: activation, regulation, modification and function.

Ning S, Pagano JS, Barber GN.

Genes Immun. 2011 Sep;12(6):399-414. doi: 10.1038/gene.2011.21. Epub 2011 Apr 14. Review.

3.

The Latent Membrane Protein 1 (LMP1).

Kieser A, Sterz KR.

Curr Top Microbiol Immunol. 2015;391:119-49. doi: 10.1007/978-3-319-22834-1_4. Review.

PMID:
26428373
4.

Expression, biological activities and mechanisms of action of A20 (TNFAIP3).

Verstrepen L, Verhelst K, van Loo G, Carpentier I, Ley SC, Beyaert R.

Biochem Pharmacol. 2010 Dec 15;80(12):2009-20. doi: 10.1016/j.bcp.2010.06.044. Epub 2010 Jul 3. Review.

PMID:
20599425
5.

NF-κB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1.

Ersing I, Bernhardt K, Gewurz BE.

Viruses. 2013 Jun 21;5(6):1587-606. doi: 10.3390/v5061587. Review.

6.

The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.

Vereecke L, Beyaert R, van Loo G.

Trends Immunol. 2009 Aug;30(8):383-91. doi: 10.1016/j.it.2009.05.007. Epub 2009 Jul 28. Review.

PMID:
19643665
7.

CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.

Sun SC.

Cell Death Differ. 2010 Jan;17(1):25-34. doi: 10.1038/cdd.2009.43. Review.

8.

The biology of A20-like molecules.

Enesa K, Evans P.

Adv Exp Med Biol. 2014;809:33-48. Review.

PMID:
25302364
9.

Anti-viral tetris: modulation of the innate anti-viral immune response by A20.

Arguello M, Paz S, Ferran C, Moll HP, Hiscott J.

Adv Exp Med Biol. 2014;809:49-64. Review.

PMID:
25302365
10.

A20: linking a complex regulator of ubiquitylation to immunity and human disease.

Ma A, Malynn BA.

Nat Rev Immunol. 2012 Nov;12(11):774-85. doi: 10.1038/nri3313. Epub 2012 Oct 12. Review.

11.

A20 in inflammation and autoimmunity.

Catrysse L, Vereecke L, Beyaert R, van Loo G.

Trends Immunol. 2014 Jan;35(1):22-31. doi: 10.1016/j.it.2013.10.005. Epub 2013 Nov 15. Review.

PMID:
24246475
12.

A20: from ubiquitin editing to tumour suppression.

Hymowitz SG, Wertz IE.

Nat Rev Cancer. 2010 May;10(5):332-41. doi: 10.1038/nrc2775. Epub 2010 Apr 12. Review.

PMID:
20383180

Supplemental Content

Support Center